FOXG1 and non-small cell lung carcinoma: Functional assays revealed that FOXG1/KD sensitizes NSCLC cells to cisplatin, while the combination of coclaurine and FOXG1/KD does not increase the sensitivity of NSCLC cells to cisplatin compared to coclaurine treatment alone (Figure 6J), consistent with the Western blot finding.